Health in Lower-middle income (World Bank) 156 indicators covering health for Lower-middle income (World Bank). IndicatorLatest Year10-yr change Rank Mean BMI (kg/m²) 23 2016 up 3.6% 10th Rubella - number of reported cases 4,725 2025 down 32.7% 4th Treatment success rate: new TB cases 90 2023 up 3.4% 3rd Yellow fever - number of reported cases 134 2025 up 538.1% 6th UHC Service Coverage sub-index on infectious diseases 67 2023 up 28.8% 11th UHC Service Coverage sub-index on service capacity and access 63 2023 up 6.8% 10th UHC Service Coverage sub-index on reproductive, maternal, newborn and 66 2023 down 1.5% 10th UHC Service Coverage Index 63 2023 up 10.5% 10th UHC Service Coverage sub-index on noncommunicable diseases 57 2023 up 14.0% 11th Stillbirth rate 16.31 2023 down 22.0% 4th Rotavirus vaccines completed dose (RotaC) immunization coverage among 70.0% 2025 up 366.7% 3rd Current health expenditure (CHE) as percentage of gross domestic 5.4% 2023 up 2.5% 10th External health expenditure (EXT) as percentage of current health 16.7% 2023 down 4.2% 3rd Domestic general government health expenditure (GGHE-D) as percentage 40.5% 2023 up 5.7% 9th Out-of-pocket expenditure as percentage of current health expenditure 36.6% 2023 down 5.4% 4th Domestic general government health expenditure (GGHE-D) as percentage 2.3% 2023 up 9.6% 9th Domestic general government health expenditure (GGHE-D) as percentage 7.8% 2023 up 11.1% 9th Domestic private health expenditure (PVT-D) as percentage of current 42.8% 2023 down 3.2% 4th Current health expenditure (CHE) per capita in US$ 146.96 2023 up 15.9% 9th Domestic private health expenditure (PVT-D) per capita in US$ 57.35 2023 up 13.5% 9th Domestic general government health expenditure (GGHE-D) per capita in 64.75 2023 up 19.6% 10th Mumps - number of reported cases 65,763 2025 up 14.0% 5th Incidence of tuberculosis (per 100 000 population) 8.1 2023 down 64.8% 5th Congenital Rubella Syndrome - number of reported cases 221 2025 up 20.8% 6th External health expenditure (EXT) per capita in US$ 24.86 2023 up 12.4% 5th Raised blood pressure (SBP>=140 OR DBP>=90) 28.5 2019 down 7.9% 4th Raised blood pressure (SBP>=140 OR DBP>=90) 27.3 2019 down 5.9% 6th Hypertension: diagnosis coverage among adults aged 30-79 with 43.1% 2019 up 24.2% 8th Hypertension among adults aged 30-79 years, prevalence 33.5 2019 down 1.2% 6th Hypertension effective treatment coverage (controlled hypertension) 14.3% 2019 up 68.2% 8th Hypertension: effective treatment coverage (controlled hypertension) 13.9% 2019 up 67.5% 8th Hypertension treatment coverage among adults aged 30-79 with 31.4% 2019 up 25.6% 8th Hypertension treatment coverage among adults aged 30-79 with 32.6% 2019 up 24.4% 8th Hypertension: diagnosis coverage among adults aged 30-79 with 41.9% 2019 up 25.4% 8th Hypertension among adults aged 30-79 years, prevalence, crude 32 2019 up 0.9% 7th Pneumococcal conjugate second or third-dose vaccines (PCVc) 81.0% 2025 up 161.3% 4th Treatment success rate: previously treated TB cases 88 2023 up 27.5% 2nd Prevalence of insufficient physical activity among adults aged 18+ 37.3% 2022 up 30.0% 3rd Prevalence of insufficient physical activity among adults aged 18+ 38.2% 2022 up 27.5% 3rd TB patients with known HIV status 84.0% 2024 up 61.5% 5th Confirmed cases of RR-/MDR-TB 89,929 2024 up 77.5% 2nd Tested TB patients HIV-positive 3.6% 2024 down 70.0% 8th New cases tested for RR-/MDR-TB 88.0% 2024 up 1,233.3% 3rd Age-standardized suicide rates 9.44 2021 down 19.5% 6th Premature deaths due to noncommunicable diseases (NCD) as a 55.84 2021 down 2.9% 4th Total NCD Deaths 12.17 million 2021 up 30.9% 4th Probability (%) of dying between age 30 and exact age 70 from any of 23.0% 2021 down 1.3% 2nd Life expectancy at age 60 16.56 2021 down 8.6% 9th Age-standardized NCD mortality rate 574.53 2021 down 2.9% 4th Mortality rate attributed to unintentional poisoning 0.4126 2021 down 11.2% 9th Life expectancy at birth 67.22 2021 up 0.3% 9th Adult mortality rate (probability of dying between 15 and 60 years) 205.68 2021 up 7.6% 3rd Previously treated cases tested for RR-/MDR-TB 85.0% 2024 up 30.8% 4th Healthy life expectancy (HALE) at age 60 12.34 2021 down 8.2% 10th nMx - age-specific death rate between ages x and x+n 0.0354 2021 down 27.0% 4th nLx - person-years lived between ages x and x+n 97,344 2021 up 1.0% 8th lx - number of people left alive at age x 100,000 2021 unchanged 1st nqx - probability of dying between ages x and x+n 0.0345 2021 down 26.3% 4th Tx - person-years lived above age x 6.72 million 2021 up 0.3% 9th Healthy life expectancy (HALE) at birth 58.26 2021 up 0.5% 9th ← Previous Page 2 of 3 Next →